Eržen, S., Tonin, G., Jurišić Eržen, D. i Klen, J. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences, 25. (3). doi: 10.3390/ijms25031517
Eržen, Stjepan, et al. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences, vol. 25, br. 3, 2024. https://doi.org/10.3390/ijms25031517
Eržen, Stjepan, Gašper Tonin, Dubravka Jurišić Eržen i Jasna Klen. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity." International Journal of Molecular Sciences 25, br. 3 (2024). https://doi.org/10.3390/ijms25031517
Eržen, S., et al. (2024) 'Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity', International Journal of Molecular Sciences, 25(3). doi: 10.3390/ijms25031517
Eržen S, Tonin G, Jurišić Eržen D, Klen J. Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences [Internet]. 26.01.2024. [pristupljeno 12.11.2024.];25(3). doi: 10.3390/ijms25031517
S. Eržen, G. Tonin, D. Jurišić Eržen i J. Klen, "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity", International Journal of Molecular Sciences, vol. 25, br. 3, Siječanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:095919. [Citirano: 12.11.2024.]